3809 results for «2270»
3809 results
TAVI in challenging scenarios
17 Nov 2025 – From PCR London Valves 2025
This session explores complex and emergent scenarios in TAVI, featuring cases such as emergent transfemoral TAVI in failing homograft roots complicated by extensive aortic dissection, the use of BASILICA in high-risk left main occlusion terrain, and the aorto-mitral challenges during TAVR. It also covers innovative coronary...
Transcatheter mitral valve-in-valve: alternative strategy for optimal alignment
17 Nov 2025 – From PCR London Valves 2025
This session focuses on transcatheter mitral valve-in-valve procedures, emphasizing alternative strategies for optimal alignment and lifetime management planning. It delves into engineering the landing zone for challenging anatomies, the integration of the LAMPOON procedure in TMVR valve-in-valve cases, and addresses complexities arising from mitral annular calcification.
TAVI Valve-in-Valve: Managing unexpected anatomical challenges
17 Nov 2025 – From PCR London Valves 2025
This session examines valve-in-valve interventions in TAVI, highlighting management of concomitant left main disease, unique case narratives such as "The Highlander story," and the unpredictability inherent in these procedures. It also reviews successful transfemoral TAV-in-SAV interventions in acute heparin-induced thrombocytopenia and addresses treatment of degenerated sutureless...
Paravalvular leak closure - Part 2
17 Nov 2025 – From PCR London Valves 2025
This session is dedicated to paravalvular leak (PVL) closure techniques, featuring percutaneous approaches after surgical valve implantation and TAVI complications such as annulus rupture. It includes advanced management using multiple plugs for long-tunnel mitral PVLs, innovative transformation from pop-up to plug strategies, and transapical approaches following...
TAVI for pure aortic regurgitation: different animal, different challenges, different approaches
17 Nov 2025 – From PCR London Valves 2025
This session delves into the unique anatomical and pathophysiological challenges posed by pure aortic regurgitation and their impact on treatment strategies. It reviews clinical outcomes with established and new transcatheter devices, and presents emerging technologies that promise to advance therapeutic options for this distinct patient population.
Mitral TEER and LAA closure: LIVE Educational Case from Clinique Pasteur - Toulouse, France
17 Nov 2025 – From PCR London Valves 2025
This educational session presents a live case from Clinique Pasteur, Toulouse, France, focusing on Mitral Transcatheter Edge-to-Edge Repair (TEER) combined with Left Atrial Appendage (LAA) closure. Attendees gain insights into patient evaluation, operator strategies, device selection, and procedural execution, complemented by a recorded case from Upper...
From diagnosis to device: decision-making and planning for mitral valve interventions
17 Nov 2025 – From PCR London Valves 2025
This session offers a comprehensive overview of decision-making and procedural planning for transcatheter mitral valve interventions. It emphasizes patient-specific factors, advanced imaging for valve morphology assessment, device selection, and the integration of emerging technologies to tailor optimal treatment strategies for mitral valve disease.
Early Career Research Award Final
17 Nov 2025 – From PCR London Valves 2025
Highlighting pioneering research in structural heart interventions, this session presents studies on the impact of transcatheter tricuspid valve replacement (TTVR) on left ventricular geometry and function, myocardial remodeling in aortic stenosis, physiological responses after mitral and tricuspid edge-to-edge repairs, advancing the understanding of device effects on...
TAVI in patients with concomitant valve and coronary artery disease
17 Nov 2025 – From PCR London Valves 2025
Focused on patients with concomitant valve and coronary artery disease, this session examines evaluation strategies for aortic stenosis burden, integrates recent trial data on combined TAVI and PCI, and discusses optimal management approaches in complex multi-valve disease scenarios through detailed case presentations and clinical outcomes.
Learning from lived experience and contemporary evidence: shaping the treatment of women with heart valve disease
17 Nov 2025 – From PCR London Valves 2025
This session provides an in-depth exploration of the lived experiences of women with valvular heart disease, emphasizing the unique challenges in detection, diagnosis, treatment, and follow-up. It integrates contemporary evidence and the forthcoming 2025 ESC/EACTS guidelines to offer practice-ready strategies tailored to the management of valvular...
TAVI valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
This session presents complex valve-in-valve TAVI cases, illustrating advanced techniques such as valve fracture and snaring in difficult anatomies, approaches for pure aortic regurgitation in degenerated surgical valves, and strategies overcoming challenges in stentless bioprostheses and previous aortic repairs.
Challenging mitral valve-in-valve
16 Nov 2025 – From PCR London Valves 2025
Gain insights into challenging mitral valve-in-valve procedures addressing small cavity anatomy, alignment difficulties, combined LAMPOON and leak closure techniques, and high-risk TMVR cases with complex left ventricular outflow tract obstruction and ECMO support.
Transcatheter tricuspid valve replacement: LIVE Educational Case from St. Thomas' Hospital - London, UK
18 Nov 2025 – From PCR London Valves 2025
This educational session presents a live transcatheter tricuspid valve replacement case from St. Thomas' Hospital, London, complemented by detailed patient imaging analysis and operator strategy. Additionally, a recorded case from the Upper Silesian Medical Center in Poland provides further insights into procedural nuances and outcomes, offering...
Curious TAVI scenarios - Part 3
18 Nov 2025 – From PCR London Valves 2025
This session examines unusual and challenging clinical scenarios following TAVI, including presentations of cyanosis, evolving valvular defects such as growing paravalvular holes, atypical imaging findings, paradoxical transvalvular gradients switching from aortic regurgitation to stenosis resolved by postdilatation, and bicoronary protection techniques in patients with low coronary...
Invasive treatment of refractory angina
20 May 2025 – From EuroPCR 2025
Explore invasive treatment options for refractory angina through clinical case presentations emphasizing coronary physiology guidance, coronary microvascular disease management, and innovative therapies such as coronary sinus reducer implantation. This session highlights provocative test-guided approaches to optimize patient outcomes.
The new global era of patient care with CathWorks FFRangio
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session highlights how CathWorks FFRangio is reshaping coronary physiology assessment worldwide. Through case-based experience and real-world data, it showcases the integration of FFRangio into routine clinical workflows—from early adoption at Clinique Pasteur in Toulouse to implementation across the UK. The session also presents...
The role of large-bore thrombectomy in my approach to pulmonary embolism management
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of the use of large-bore thrombectomy in the management of pulmonary embolism. It highlights key clinical considerations for intervention, including the potential to reduce fatal events, prevent long-term complications, and optimize cost-effectiveness in eligible patients. A real-life case involving a 65-year-old patient...
Nurses and allied professionals abstracts session
20 May 2025 – From EuroPCR 2025
Highlight the pivotal role of nurses and allied health professionals in interventional cardiology through a series of abstracts addressing radial haemostasis, TAVI nursing programs, early mobilization, radiation protection, and physiologist-led intracoronary thermodilution assessments.
Transforming PCI: mastering the implementation of drug-eluting balloons
22 May 2025 – From EuroPCR 2025
This EuroPCR 2025 session provides a comprehensive overview of drug-eluting balloons (DEBs) and their growing role in percutaneous coronary intervention (PCI). Gain a clear understanding of the clinical evidence and rationale supporting DEBs, including how these devices minimize metal implantation and effectively treat both standard and...
Treat calcium right the first time: new considerations for PCI planning and device selection to optimise outcomes
21 May 2025 – From EuroPCR 2025
Watch this EuroPCR 2025 session to learn how intravascular lithotripsy (IVL) is transforming the management of coronary artery calcification (CAC). Discover the new CALC roadmap, a comprehensive framework guiding device selection and treatment strategies based on calcium burden, anatomy, and patient gender. Follow a real-world clinical...
